Durvalumab vs Sacubitril-Valsartan

Durvalumab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between Durvalumab and Sacubitril-Valsartan.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Sacubitril-Valsartan — 11.5 hours.

Chemical Properties

Molecular Formula: Sacubitril-Valsartan — C24H29N2O5.

Molecular Weight: Sacubitril-Valsartan — 414.5010 g/mol.

Type: Durvalumab — Antibody; Sacubitril-Valsartan — Small molecule.